Company Calithera Biosciences, Inc.

CALA

US13089P5070

Pharmaceuticals

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals

Delayed OTC Markets Other stock markets 15:27:51 29/04/2024 BST			5-day change	1st Jan Change
0.02 ^USD	0.00%		-31.03%	-33.33%

2023	Calithera Biosciences, Inc. Launches the Cala kIQ System, Offering Meaningful Tremor Relief for Patients with Essential Tremor and Now Parkinson’s Disease	CI
2023	North American Morning Briefing : Stock Futures -2-	DJ

Calithera Biosciences, Inc. is a shell company. The Company is winding up its operations. The Company is seeking to sell all of its clinical assets and programs. The Company has not generated any revenue.

Number of employees: 9

Managers	Title	Age	Since
Susan Molineaux FOU	Founder	70	08/03/10
Stephanie Wong DFI	Director of Finance/CFO	50	31/03/14
Keith Orford BRD	Director/Board Member	52	31/12/14
Christopher J. Molineaux PRN	Corporate Officer/Principal	70	31/03/13

Members of the board	Title	Age	Since
J. Garland BRD	Director/Board Member	55	09/07/20
Henry Ward Wolff BRD	Director/Board Member	75	01/12/14
Deepa Pakianathan BRD	Director/Board Member	59	31/08/12
Susan Molineaux FOU	Founder	70	08/03/10
Suzy Jones BRD	Director/Board Member	58	09/08/16
Sunil Agarwal BRD	Director/Board Member	54	28/09/15
Keith Orford BRD	Director/Board Member	52	31/12/14
Blake Wise BRD	Director/Board Member	53	20/09/17

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	4,872,497	4,820,174 ( 98.93 %)	0	98.93 %
Stock B	0	1,000,000	0	0

Name	Equities	%	Valuation
BVF Partners LP 9.538 %	464,742	9.538 %	11 619 $
Citadel Advisors LLC 5.117 %	249,336	5.117 %	6 233 $
Susan Molineaux 0.7274 %	35,441	0.7274 %	886 $
Eric B. Sjogren 0.1738 %	8,467	0.1738 %	212 $
Stephanie Wong 0.1210 %	5,897	0.1210 %	147 $
Emil T. Kuriakose 0.0688 %	3,354	0.0688 %	84 $
Hauck & Aufhäuser Fund Services SA 0.0308 %	1,500	0.0308 %	38 $
Suzy Jones 0.007368 %	359	0.007368 %	9 $
DoubleLine Capital LP 0.004679 %	228	0.004679 %	6 $
Liechtensteinische Landesbank Österreich AG 0.003079 %	150	0.003079 %	4 $

Calithera Biosciences, Inc.

343 Oyster Point Boulevard Suite 200

94080-9992, South San Francisco

+650 870 1000

http://www.calithera.com

address Calithera Biosciences, Inc.(CALA)

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
CALITHERA BIOSCIENCES, INC.	-33.33%	97.45K
ELI LILLY AND COMPANY	+25.66%	661B
NOVO NORDISK A/S	+26.74%	566B
JOHNSON & JOHNSON	-6.59%	352B
MERCK & CO., INC.	+19.50%	332B
ABBVIE INC.	+3.70%	283B
ASTRAZENECA PLC	+13.43%	231B
NOVARTIS AG	+4.71%	200B
ROCHE HOLDING AG	-9.53%	195B
AMGEN INC.	-4.90%	145B

Other Pharmaceuticals